Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Ivermectin susceptibility and sporontocidal effect in Greater Mekong Subregion Anopheles.

Kobylinski KC, Ubalee R, Ponlawat A, Nitatsukprasert C, Phasomkulsolsil S, Wattanakul T, Tarning J, Na-Bangchang K, McCardle PW, Davidson SA, Richardson JH.

Malar J. 2017 Jul 7;16(1):280. doi: 10.1186/s12936-017-1923-8.

2.

Case report: a new method for treatment of permethrin - resistant head lice.

Jahangiri F.

Clin Case Rep. 2017 Mar 17;5(5):601-604. doi: 10.1002/ccr3.899. eCollection 2017 May.

3.

Head Lice.

Meister L, Ochsendorf F.

Dtsch Arztebl Int. 2016 Nov 11;113(45):763-772. doi: 10.3238/arztebl.2016.0763.

4.

Efficacy and Safety of High-Dose Ivermectin for Reducing Malaria Transmission (IVERMAL): Protocol for a Double-Blind, Randomized, Placebo-Controlled, Dose-Finding Trial in Western Kenya.

Smit MR, Ochomo E, Aljayyoussi G, Kwambai T, Abong'o B, Bayoh N, Gimnig J, Samuels A, Desai M, Phillips-Howard PA, Kariuki S, Wang D, Ward S, Ter Kuile FO.

JMIR Res Protoc. 2016 Nov 17;5(4):e213.

5.

Preclinical Study of Single-Dose Moxidectin, a New Oral Treatment for Scabies: Efficacy, Safety, and Pharmacokinetics Compared to Two-Dose Ivermectin in a Porcine Model.

Bernigaud C, Fang F, Fischer K, Lespine A, Aho LS, Dreau D, Kelly A, Sutra JF, Moreau F, Lilin T, Botterel F, Guillot J, Chosidow O.

PLoS Negl Trop Dis. 2016 Oct 12;10(10):e0005030. doi: 10.1371/journal.pntd.0005030. eCollection 2016 Oct.

6.

Management and Treatment of Human Lice.

Sangaré AK, Doumbo OK, Raoult D.

Biomed Res Int. 2016;2016:8962685. doi: 10.1155/2016/8962685. Epub 2016 Jul 27. Review.

7.

Prospects for Moxidectin as a New Oral Treatment for Human Scabies.

Mounsey KE, Bernigaud C, Chosidow O, McCarthy JS.

PLoS Negl Trop Dis. 2016 Mar 17;10(3):e0004389. doi: 10.1371/journal.pntd.0004389. eCollection 2016 Mar. No abstract available.

8.

Treatment of Pediculosis Capitis.

Verma P, Namdeo C.

Indian J Dermatol. 2015 May-Jun;60(3):238-47. doi: 10.4103/0019-5154.156339. Review.

9.

Establishment of the Ivermectin Research for Malaria Elimination Network: updating the research agenda.

Chaccour CJ, Rabinovich NR, Slater H, Canavati SE, Bousema T, Lacerda M, Ter Kuile F, Drakeley C, Bassat Q, Foy BD, Kobylinski K.

Malar J. 2015 Jun 11;14:243. doi: 10.1186/s12936-015-0691-6.

10.

Utilization of the human louse genome to study insecticide resistance and innate immune response.

Clark JM, Yoon KS, Kim JH, Lee SH, Pittendrigh BR.

Pestic Biochem Physiol. 2015 May;120:125-32. doi: 10.1016/j.pestbp.2014.11.008. Epub 2014 Nov 20. Review.

11.

The biology and taxonomy of head and body lice--implications for louse-borne disease prevention.

Bonilla DL, Durden LA, Eremeeva ME, Dasch GA.

PLoS Pathog. 2013;9(11):e1003724. doi: 10.1371/journal.ppat.1003724. Epub 2013 Nov 14. Review. No abstract available.

12.

Ivermectin inhibits growth of Chlamydia trachomatis in epithelial cells.

Pettengill MA, Lam VW, Ollawa I, Marques-da-Silva C, Ojcius DM.

PLoS One. 2012;7(10):e48456. doi: 10.1371/journal.pone.0048456. Epub 2012 Oct 30.

13.

An incurable itch: head lice.

Smith CH, Goldman RD.

Can Fam Physician. 2012 Aug;58(8):839-41. Review.

14.

Brief exposures of human body lice to sublethal amounts of ivermectin over-transcribes detoxification genes involved in tolerance.

Yoon KS, Strycharz JP, Baek JH, Sun W, Kim JH, Kang JS, Pittendrigh BR, Lee SH, Clark JM.

Insect Mol Biol. 2011 Dec;20(6):687-99. doi: 10.1111/j.1365-2583.2011.01097.x. Epub 2011 Sep 7.

15.

Head lice.

Burgess IF.

BMJ Clin Evid. 2011 May 16;2011. pii: 1703. Review.

Supplemental Content

Support Center